Insulin resistance is one area under investigation. If you have been diagnosed with the condition, here’s how GLP-1s may help ...

Physical activity is one of the most powerful tools for managing diabetes, but experts say exercising safely requires ...

Though the warm, long days of summer are right around the corner, it's never too late to break out the slow cooker. From comforting soups to fluffy bread, slow cookers are the ultimate ...

What Is It, and Why Does It Matter? Tzield (teplizumab-mzwv) is a prescription immune therapy that can help delay the progression of type 1 diabetes (T1D). The FDA has approved Tzield for slowing the ...

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.

NEW ORLEANS — In adults with type 2 diabetes (T2D) who are not treated with insulin, continuous glucose monitoring (CGM) provided substantial improvements in hyperglycemia compared with those ...

June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in patients ‌with type 2 diabetes not using insulin, compared ...

Label expansion enables a rapid-acting inhaled mealtime insulin option for pediatric patients ≥6 years, addressing injection burden amid persistent unmet needs in youth diabetes management.

Please provide your email address to receive an email when new articles are posted on . Both children and adults with type 1 diabetes had improvements in time in range using Lyumjev with the Medtronic ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The National Institutes of Health may appear to have more stable ...